Browsing Tag

BMF219s

Biomea Fusion Selected for Two Oral Presentations at the European Association for the…

Eli Pacheco Jul 1, 2022 0

Biomea to present two oral abstracts across multiple animal models highlighting the ability of BMF-219, a covalent menin inhibitor, to significantly lower HbA1C (approximately two-fold…

Health

Biomea Fusion to Present New Preclinical Data Showing BMF-219’s Strong Activity in…

Eli Pacheco May 27, 2022 0

BMF-219 is the first investigational menin inhibitor in clinical development to show potential as a therapeutic agent for CLLBMF-219, a covalent menin inhibitor, demonstrated potency across…